"Designing Growth Strategies is in our DNA"

Acute Kidney Failure Treatment Market Size, Share & Industry Analysis, By Disease Indication (Pre-renal Kidney Failure, Post-renal Kidney Failure, Intrinsic Kidney Failure), By Treatment Type (Medications/ Drug Therapy, Urinary Implants) and Regional Forecast, 2023-2030

Region : Global | Report ID: FBI101526 | Status : Ongoing



In 2015, the U.S Food and Drug Administration granted Expedited Access Pathway status to the wearable artificial kidney (WAK), which can be worn like a belt to perform hemodialysis and will be connected to patient through a catheter. Acute kidney failure refers to a medical condition in which there is sudden damage to the kidney, resulting in inability to filter waste substances from the blood.

Acute kidney failure is the most common complication in diseases such as diabetes, kidney stones, hypertension, prostate cancer, multiple myeloma, liver failure, and many others. The symptoms of acute kidney failure include abdominal pain, nausea, vomiting, dehydration, frequent backache, and others. Moreover, lifestyle habits such as smoking, alcohol consumption, and high dose medications can also lead to acute kidney failure.

To gain extensive insights into the market, Request for Customization

Global acute kidney failure treatment market growth is being driven by rapidly increasing prevalence of kidney disorders. Moreover, exponential growth of risk factors which are associated with kidney failures such as hypertension, diabetes, liver failures, and others are also expected to boost the prevalence of kidney failure, which will eventually boost the growth of the global acute kidney failure treatment market during the forecast period.

However, higher cost of acute kidney failure treatment coupled with poor reimbursement policies in emerging nations is expected to restrain the growth of the global acute kidney failure treatment market by 2026.

Key Players Covered

The major companies covered in the global acute kidney failure treatment market report include Fresenius Medical Care, Baxter, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic, Teleflex Incorporated, Pfizer Inc., Hollister Incorporated, Coloplast Corp., Cure Medical, LLC, Cook, and other players.




By Disease Indication

  • Pre-renal Kidney Failure

  • Post-renal Kidney Failure

  • Intrinsic Kidney Failure

By Treatment Type

  • Medications/ Drug Therapy

    • Diuretics

    • Fluid Replacement therapy

    • Others

  • Urinary Implants

By Geography

  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

As per the current acute kidney failure treatment market trends, drug therapy among the treatment types is projected to hold a major share of the market owing to its higher adoption as it offers comparatively higher benefits than urinary implants.

Key Insights

  • Epidemiology of acute kidney failure by key countries

  • New product launch by key players

  • Reimbursement scenario for key countries

  • Key mergers and acquisitions

Regional Analysis

The global acute kidney failure treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In North America, the global acute kidney failure treatment market is likely to grow due to the high prevalence of chronic kidney diseases. According to the Centres of Disease Control and Prevention, in 2017, 30 million people in the United States were estimated to have chronic kidney diseases, which implies a significant growth in the North America acute kidney failure treatment market during the forecast period. In Europe, higher prevalence of risk factors responsible for acute kidney failures such as smoking, hypertension, diabetes, and others are expected to boost the prevalence of acute kidney failure, which will eventually boost the demand for Europe acute kidney failure treatment market by 2026. In Asia Pacific, growing healthcare infrastructure coupled with increasing healthcare infrastructure is anticipated to offer substantial opportunity for the growth of the Asia Pacific acute kidney failure treatment market.

Acute Kidney Failure Treatment Industry Developments

  • In October 2018, the association of Mayo clinic and Baxter International Inc. announced the strategic plan to launch Renal Care Center of Excellence (RCCE) in the U.S. with the aim to offer guidance about home hemodialysis, chronic kidney disease management, and in-center hemodialysis to CKD patients.

  • In June 2018, Fresenius Medical Care and Humacyte, Inc. agreed upon a strategic partnership to validate the efficacy of HUMACYL, vascular access product for hemodialysis. Moreover, by this partnership, Fresenius Medical Care will get legal rights to commercialize HUMACYL in the global market.                                                                                           

  • Ongoing
  • 2021
  • 2018-2020


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.